In the first step taken by a global entity to tackle the coronavirus outbreak that has raised fears of a pandemic, three programmes involving two US biotech companies are trying to fast-track potential vaccines against the rampaging nCoV-2019.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment